Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
That’s according to an analysis of HIV-positive people released from jail or prison in Connecticut.
One researcher argues that the pharmaceutical industry ought to pay greater heed to such risks during drug development.
Treating hep C lowers the risk.
The study was conducted in Indonesia, Ukraine and Vietnam.
A speedy overview of the major scientific findings presented at the International AIDS Conference in Amsterdam (AIDS 2018)
These risks include hospitalization and death.
This is according to a meta-analysis of a dozen studies conducted in North America and Europe.
A recent study found that more time spent depressed meant a greater risk of missing clinic visits, having a detectable viral load and death.
In a long-term study, women who spent more time living with depression were more likely to die.
A recent study in Africa parsed the factors that predicted death after people with a CD4 count below 100 started antiretrovirals.
Aside from taking antiretrovirals, quitting smoking is the number one way people with HIV can lower their risk of illness and death.
A Canadian study found that factors such as employment and housing status, income and education were associated with mortality.
Being coinfected with hepatitis C and having a higher HIV viral load are also associated with such a risk according to a recent study.
Known as polypharmacy, taking numerous medications has been linked to such risks in the general population as well.
Researchers urge clinicians to closely monitor their patients with HIV and chronic kidney disease.
Depression was associated with missed clinic appointments, a detectable viral load and a greater risk of death in a recent large study.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.